Path: utzoo!utgpu!water!watmath!uunet!ig!daemon From: MJB1@VMS-SUPP.CAM.AC.UK Newsgroups: bionet.molbio.seqnet Subject: SEQNET Bulletin Message-ID: <4778@ig.ig.com> Date: 19 Jan 88 15:22:05 GMT Sender: daemon@presto.ig.com Lines: 203 From: MJB1@VMS-SUPP.CAM.AC.UK Bulletin_# 62 From: SEQNET 19 Jan 88 Common Data Submission Policy Subject: Common Data Submission Policy From: SEQNET Date: 19 Jan 88 COMMON DATA SUBMISSION POLICY The major Nucleic Acid and Protein Sequence Database Centres have agreed a common data submissions policy. Under this policy, data submitted to any one of the participating members will be shared by all others. As submitted data will be directly transmitted by the databases, research scientists need submit data to only one of these groups. The groups are: GenBank Genetic Sequence Data Bank (GENBANK) genbank%arpa.bionet-20@uk.ac.rl.earn European Molecular Biology Laboratory (EMBL) datasubs%embl@uk.ac.rl.earn DNA Data Bank of Japan (DDBJ) National Institute of Genetics National Biomedical Research Foundation (NBRF-PIR) Protein Information Resource pirsub%gunbrf@uk.ac.rl.earn Martinsreid Institute for Protein Sequence Data (MIPS) Max Planck Institute for Biochemistry mips%dm0mpb51@uk.ac.rl.earn International Protein Information Database in Japan (JIPID) Science University of Tokyo Please fill in the forms provided for submitting your entry. A program to aid proper completion of forms is expected soon. =============================================================================== Your name ------------------------------------------------------------------------------ Organization ------------------------------------------------------------------------------ Address ------------------------------------------------------------------------------ Telephone Computer network address ============================================================================== On what medium and in what format are you sending your sequence data? (see end of this form for instructions) [ ] magnetic tape: density [ ] 800 [ ] 1600 [ ] 6250 character code [ ] ASCII [ ] EBCDIC record length ______________ blocksize ______________ label type _________________ [ ] electronic mail [ ] diskette: computer ________________ operating system _______________ [ ] printed copy =============================================================================== CITATION INFORMATION =============================================================================== These data will be published by authors ______________________________________________________________________________ title of paper ______________________________________________________________________________ journal ------------------------------------------------------------------------------ vol, pages,year (if known) ============================================================================== Does the sequence which you are sending with this form include data that does not appear in the above journal article? [ ] yes, beginning at base number _____ and ending at base _____ [ ] no How should this data be cited in the database? authors ------------------------------------------------------------------------------ title of paper (if applicable) ------------------------------------------------------------------------------ journal (if applicable) vol,pages,year ============================================================================== Please list references to papers and/or database entries which report sequences overlapping with data submitted here. ------------------------------------------------------------------------------ first author journal, vol., pages, year OR database, accession number ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ ============================================================================== DESCRIPTION OF SEQUENCED SEGMENT Where appropriate, please use standard nomenclature or conventions. NOT ALL QUESTIONS ARE RELEVANT TO ALL SEQUENCES. =============================================================================== What kind of molecule does this sequence represent? [ ] genomic DNA [ ] tRNA [ ] organelle DNA (please specify) ______________ [ ] rRNA [ ] cDNA [ ] snRNA [ ] other nucleic acid __________________________ [ ] scRNA [ ] peptide sequence assembled by [ ] overlap of sequenced fragments [ ] homology with related protein sequence [ ] other (please specify) _____________________ ------------------------------------------------------------------------------- length of sequence [ ] bp or [ ] amino acid residues ------------------------------------------------------------------------------- library (type, name) clone(s) ------------------------------------------------------------------------------- genomic location/map position gene name(s) (e.g., lacZ) ------------------------------------------------------------------------------- gene product name(s) (e.g., beta-D-galactosidase) and Enyme Commission number ------------------------------------------------------------------------------- source organism (Latin name) (e.g., Mus musculus) ------------------------------------------------------------------------------- strain (e.g., BALB/c) haplotype ------------------------------------------------------------------------------- tissue/cell line source [ ] germ line [ ] rearranged =============================================================================== FEATURES OF THE SEQUENCE Please list below the first and last base/residue numbers of all significant features identified within the sequence. In the column marked "id," indicate the method by which the feature was identified (E = experimentally; S = by similarity with another sequence; C = match to an established consensus sequence). For nucleotide sequences, indicate (by writing an x in the column marked "comp") if the feature is encoded by the strand complementary to that reported here. Some examples of significant features are: - regulatory signals (e.g., promoters, attenuators, enhancers) - transcribed regions (mRNA, rRNA, tRNA, etc.) - regions subject to post-transcriptional modification (e.g., introns, modified bases) - translated regions - extent of signal peptide, prepropeptide, propeptide, mature peptide - sites subject to post-translational modification (glycosylation, phosporylation) - other domains/sites of interest (e.g., extracellular domain, DNA-binding domain, active site, inhibitory site) - sites involved in bonding (disulfide, thiolester, intrachain, interchain) - regions of alpha helix or beta pleated sheet ================================================================================ Numbering for features on the sequence you are submitting to us [ ] starts at 1 OR [ ] starts at _______ Does the numbering match that in your manuscript? [ ] yes [ ] no -------------------------------------------------------------------------------- feature from to id comp ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ------------------------------------------- --------- --------- ----- --------- ================================================================================ KEYWORDS =============================================================================== Describe the properties of the sequence in terms of its associated phenotype(s), the biological/enzymatic activity of its product and the general functional classification of the gene and/or gene product. Also indicate macromolecules which the gene product can bind (e.g., DNA; Ca++; other proteins), subcellular localization of the gene product and any other information you think is relevant. EXAMPLE (for the viral erbB gene sequence): transforming capacity; EGF receptor-related; transmembrane protein; tyrosine kinase; oncogene. ------------------------------------------------------------------------------- ===============================================================================